We aim to enhance cardiovascular health in the community through innovative research, led by our physician scientists who bring a wealth of practical experience to our projects.
At AmstelHeart we strive to become a leading cardiovascular research group that generates and shares meaningful evidence to enhance cardiovascular health in the community and primary care in particular. Our values of integrity, respect, curiosity, and teamwork guide our daily actions and decisions.
We focus on developing decision aids for triage, diagnosis, and management of common cardiovascular diseases, such as atrial fibrillation, heart failure, and coronary heart disease. Additionally, we aim to improve cardiovascular risk prediction by incorporating diversity markers like ethnicity, as well as management to help improve brain-related outcomes, with specific interest in dementia.
We provide a learning platform for junior researchers, bachelor's, and master's students to gain experience in community-oriented cardiovascular research. At AmstelHeart, we believe in blending one-on-one and group mentoring embedded in a low-key, supportive work environment. Many of our students progress to careers in primary care, often with an academic research focus.
We’re excited to announce a new collaboration between the AmstelHeart research group (Amsterdam UMC) and Star-shl to evaluate the TRACE care pathway—a primary care diagnostic service for chest pain in the Rotterdam-Rijnmond region.
Joshua van Apeldoorn will defend the dissertation 'Ethnicity and cardiovascular prevention in Dutch primary care'. Supervisors are Prof. E.P. Moll van Charante and Prof. C.O. Agyemang. The co-supervisors are Dr R.E. Harskamp and Prof. E. Richard.
Namens AmstelHeart heeft Ralf Harskamp de DCVA netwerkbijeenkomst 2025 helpen organiseren. Aanmelden kan hier. De bijeenkomst is op 6 maart in Bar Beton (Utrecht Centraal), entree vanaf 17.30 uur. Er zijn geen kosten verbonden aan deelname.
Op de NHG wetenschapsdag zijn onze onderzoekers actief in 3 sessies.
A national survey conducted by NIVEL among Dutch GPs revealed strong support for the early detection of patients at high risk for cardiovascular disease. The findings indicated that selective screening can effectively occur in general practice, provided there are adequate time and resources available. This commitment resonates deeply with our mission.
Our group is also aligned with the seven strategic goals of the Dutch Heart Foundation's 2024 national agenda:
